ESCCA 2022

The ESCCA Conferences have become of major importance for education and scientific exchange in the fields of basic, translational and clinical applications in cytometry, in particular, flow cytometry applications and in Hematology, Immunology, Cancer and Cell Biology.

ESCCA 2022 will take place in Belfast, Northern Ireland, from Wednesday 21 - Saturday 24 September 2022.

scientific programme

The programme will include plenary sessions, educational tracks in the fields of Hematology-Oncology, Data analysis and Immunology, and  abstract and poster presentations. 

The parallel sessions (PAR) cover 3 educational tracks: Advances in hemato-oncological diseases, Fundamentals in Clinical Flow and Antigen specific immunology in disease.

You are welcome to submit an abstract for oral presentation or for presentation as a poster. Please see the Abstracts page for more information. Deadline for submission is 30 June!

You can download the preliminary programme at a glance and the full programme via the buttons here below.

pre-conference training courses

On Wednesday 21 September 2022 from 09.00-12.30 hrs., five pre-conference training courses will take place for a limited number of participants. 

Training course 1: B-cell analysis in immunodeficiencies, autoimmunity and infections
This course has been cancelled

Training course 2: Measurable residual disease in MM
Organiser: Juan Flores-Montero
Level: Advanced. Max. 20 places. 

Measurable residual disease (MRD) detection during follow-up is one of the aspects currently drawing more attention in multiple myeloma (MM). Growing evidence is being gathered that confirms the clinical relevance of MRD detection, particularly for the most recent high-sensitive methodologies, as they continue to move closer to the routine clinical laboratory. In this curse we will review the utility of MRD detection in clinical practice and, deepen our understanding on the Next Generation Flow methodology by gaining first-hand practical experience on data analysis, interpretation and reporting. 
Download the programme

Training course 3: Platelet characterization by flow cytometry
Organiser: José Enrique O’Connor (Valencia, ES) 
Level: Basic. Max 20 participants.

Throughout this course participants will be guided through the fascinating world of platelet cytometry. Platelet phenotype and functional responses have been considered traditionally complicated aspects for clinical cytometry. However, most difficulties in platelet cytometry are overcome by appropriate sample preparation and by carefully designed flow cytometric setup and assay optimization. The state of the art in platelet flow cytometry has made its way far beyond the description of hemostatic disorders. The course will illustrate the relevance and practical application of multiparametric flow cytometry to the clinical analysis of platelet and platelet-derived microvesicles. Special focus will be put on the technical bases of sample preparation, including guidelines for assay optimization and standardization. Participants will gain practical experience by analyzing listmode files of real cases from diagnostic, prognostic and therapeutic settings. 
Download the programme

Trainng course 4: Validation and ISO accreditation of FCM assays
Organisers: Iuri Marinov (Prague, CZ) and Frank Preijers (Nijmegen, NL)
Level: Advanced. Max 20 participants.

In the first part of the course participants will receive a comprehensive review of the Regulation (EU) 2017/746 on in vitro diagnostic medical devices. During the second part participants will learn the approaches for preanalytical, analytical and postanalytical validation procedures for in-house FCM methods. In the last part participants will gain understanding of the requirements for ISO 5189 accreditation. 
Download the programme

Trainng course 5: AML-MRD
Organiser: Willemijn Hobo (Nijmegen, NL)
Level: Advanced. Max 20 participants.

Treatment intensity of acute myeloid leukemia (AML) patients is based on prognostic risk classification. One of the most important prognostic factors in AML is measurable residual disease (MRD) after intensive chemotherapy and therefore incorporated in clinical practice to select the appropriate consolidation treatment. Although molecular techniques are available, flow cytometry is currently the most commonly used. Recently the ELN AML MRD working party (ELN-DAVID) has published the latest technical insights (PMID: 34964040). Based on this, in this course we (Francesco Buccisano, Jacqueline Cloos and colleagues) will provide details on the different flow techniques and which facets of the measurements are key for accurate and good quality measurements, such as instrument settings, sample preparation, data analysis and reporting.
Download the programme


ESCCA members will be able to take the official ESCCA European Cytometry Certification Examination online. More information will be announced in the Membership section of the ESCCA website in the summer of 2022. Please do not register yet. Registration will open as soon as the online exams are available.

ESCCA is grateful for its main 2022 Conference sponsors
Sponsor Beckman Coulter
Sysmex sponsor


European Society for Clinical Cell Analysis (ESCCA)
p/a Kinderdijkstraat 14 II
1079 GH Amsterdam
The Netherlands

Correspondence to

Juan Flores Montero, ESCCA Secretary

Social media